To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases
CRISPR/Cas has emerged as an excelle nt gene-editing technology and is used worldwide for research. The CRISPR library is an ideal tool for identifying essential genes and synthetic lethality targeted for cancer therapies in human cancers. Synthetic lethality is defined as multiple genetic abnormali...
Guardado en:
Autores principales: | Iichiroh Onishi, Kouhei Yamamoto, Yuko Kinowaki, Masanobu Kitagawa, Morito Kurata |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/875a5219042e49beb189ce78fc532fab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A Genome-Wide CRISPR/Cas9-Based Screen Identifies Heparan Sulfate Proteoglycans as Ligands of Killer-Cell Immunoglobulin-Like Receptors
por: Klara Klein, et al.
Publicado: (2021) -
Development of a CRISPR/Cas9-Based Tool for Gene Deletion in <italic toggle="yes">Issatchenkia orientalis</italic>
por: Vinh G. Tran, et al.
Publicado: (2019) -
Bioinformational analysis of Yersinia pseudotuberculosis IP32953 CRISPR/cas system
por: N. P. Peretolchina, et al.
Publicado: (2016) -
Disabling a Type I-E CRISPR-Cas Nuclease with a Bacteriophage-Encoded Anti-CRISPR Protein
por: April Pawluk, et al.
Publicado: (2017) -
High‐efficiency delivery of CRISPR‐Cas9 by engineered probiotics enables precise microbiome editing
por: Kevin Neil, et al.
Publicado: (2021)